CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 125 enrolled
Drug / intervention
acne system - benzoyl peroxide 2.5%, Salicyclic Acid 0.5%other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01446237
NCT01446237N/ACompleted
CompareCT.gov

An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne

Stiefel, a GSK Company·interventional·Posted Oct 5, 2011·Updated May 25, 2017

In Brief

A clinical study evaluating acne system - benzoyl peroxide 2.5%, Salicyclic Acid 0.5% for Acne Vulgaris. Completed, enrolled 125 participants across 9 sites.

Detailed Summary

This study is being conducted to obtain safety, efficacy, and satisfaction data on the combination of topical Benzoyl Peroxide (BPO) 2.5% and the topical keratolytic agent Salicylic Acid (SA) 0.5% in the treatment of moderate to severe acne. Subjects with moderate or severe acne will be asked to apply the commercially available, over-the-counter products Foam Deep Cleanser (2.5% BPO), Foam Advanced Acne Treatment (2.5% BPO), and Foam Rejuvenating Toner (0.5% SA) daily for 12 weeks. No control group or reference treatment will be included.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
CollaboratorsGlaxoSmithKline

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedOct 5, 2011
Enrollment StartJun 1, 2011
Primary CompletionDec 1, 2011
Study CompletionDec 15, 2011
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 14.7 years ago

Interventions

acne system - benzoyl peroxide 2.5%, Salicyclic Acid 0.5%other

over the counter acne system